SFFS
DGX icon

Stonehage Fleming Financial Services’s Quest Diagnostics DGX Stock Holding History

Stonehage Fleming Financial Services’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,462
Closed -$124K – 302
2016
Q3 		$124K Buy
+1,462
New +$123K 0.01% 216

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Stonehage Fleming Financial Services's DGX Position: Q4 2016 in Review

Stonehage Fleming Financial Services sold out of Quest Diagnostics (DGX) in Q4 2016, closing a stake of 1,462 shares — an estimated $124K sold.

Stonehage Fleming Financial Services first reported a position in DGX in Q3 2016 and held it in 1 quarter. The position peaked at $124K in Q3 2016. 598 funds tracked by Wall St. Rank hold DGX as of Q4 2016.

  • Stonehage Fleming Financial Services reported no remaining Quest Diagnostics position as of Q4 2016 after selling out during the quarter.
  • Stonehage Fleming Financial Services sold 1,462 Quest Diagnostics shares in Q4 2016, an estimated $124K.
  • Stonehage Fleming Financial Services first reported a position in Quest Diagnostics in Q3 2016 and held it in 1 quarter.
  • Stonehage Fleming Financial Services's Quest Diagnostics position peaked at $124K in Q3 2016.
  • 598 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2016.

Based on Stonehage Fleming Financial Services's 13F filing for Q4 2016, filed 11 Oct 2019.